Halozyme Therapeutics Inc
NASDAQ:HALO
Halozyme Therapeutics Inc
NASDAQ:HALO
Price:
112.03
USD
-0.37%
Market Closed
Market Cap:
$13.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
US |
|
E
|
Eni SpA
OTC:EIPAF
|
IT |
|
C
|
China Coal Energy Co Ltd
SWB:CVV
|
CN |
Shareholder Yield
Current shareholder yield for HALO is
.
Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
Peers Comparison
Shareholder Yield
Shareholder Yield
Price Appreciation
HALO Price
Halozyme Therapeutics Inc
Halozyme Therapeutics Inc
Annual Price Range
112.03
52w Low
61.63
52w High
112.45
Price Metrics
| Average Annual Return | 28.61% |
| Standard Deviation of Annual Returns | 38.07% |
| Max Drawdown | -49% |
Shares Statistics
| Market Capitalization | 12.8B USD |
| Shares Outstanding | 118 610 000 |
| Percentage of Shares Shorted | 14.42% |
HALO Return Decomposition
Main factors of price return
Main factors of price return
Stock Splits
HALO's latest stock split occurred on Dec 10, 2003
The company executed a 171-for-40 stock split, meaning that for every 40 shares held, investors received 171 new shares.
The adjusted shares began trading on Dec 10, 2003. This was the only stock split in HALO's history.
Pre-Split Price
N/A
Post-Split Price
4.15
Before
After